Satoko Otsuguro - Search Results

Year	Number of Results
2016	1
2017	1
2018	2
2019	2
2020	1
2021	2
2022	4
2024	4
2025	1
2026	2

1

An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells.

Hsu CY, Yanagi T, Miyamoto K, Otsuguro S, Maenaka K, Nishihara H, Nakamura H, Takahashi K, Ujiie H. Hsu CY, et al. Among authors: otsuguro s. Br J Cancer. 2025 Jul;133(1):3-13. doi: 10.1038/s41416-025-03016-2. Epub 2025 May 29. Br J Cancer. 2025. PMID: 40442405 Free PMC article. Review.

2

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.

Mori Y, Suto K, Takei N, Yokoyama K, Chiba M, Ishio T, Goto H, Endo T, Hasegawa H, Maeda M, Otsuguro S, Maenaka K, Teshima T, Yang Y, Nakagawa M. Mori Y, et al. Among authors: otsuguro s. Leukemia. 2026 Jul 13. doi: 10.1038/s41375-026-03055-5. Online ahead of print. Leukemia. 2026. PMID: 42443409

3

Thermostability and binding properties of single-chained Fv fragments derived from therapeutic antibodies.

Tadokoro T, Tsuboi H, Nakamura K, Hayakawa T, Ohmura R, Kato I, Inoue M, Tsunoda SI, Niizuma S, Okada Y, Otsuguro S, Maenaka K. Tadokoro T, et al. Among authors: otsuguro s. Protein Sci. 2024 Jul;33(7):e5084. doi: 10.1002/pro.5084. Protein Sci. 2024. PMID: 38923711 Free PMC article.

4

Chlamydia trachomatis L2 434/Bu readily activates glycolysis under hypoxia for efficient metabolism.

Li R, Zhang S, Otsuguro S, Nagao M, Matsuda A, Thapa J, Okubo T, Maenaka K, Higashi H, Yamaguchi H. Li R, et al. Among authors: otsuguro s. Biochem Biophys Res Commun. 2024 Dec 3;736:150461. doi: 10.1016/j.bbrc.2024.150461. Epub 2024 Aug 6. Biochem Biophys Res Commun. 2024. PMID: 39128263

5

X-206 exhibits broad-spectrum anti-β-coronavirus activity, covering SARS-CoV-2 variants and drug-resistant isolates.

Sasaki J, Sato A, Sasaki M, Okabe I, Kodama K, Otsuguro S, Yasuda K, Kojima H, Orba Y, Sawa H, Maenaka K, Yanagi Y, Hashiguchi T. Sasaki J, et al. Among authors: otsuguro s. Antiviral Res. 2024 Dec;232:106039. doi: 10.1016/j.antiviral.2024.106039. Epub 2024 Nov 19. Antiviral Res. 2024. PMID: 39571911

6

Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.

Chiba M, Shimono J, Ishio T, Takei N, Kasahara K, Ogasawara R, Ara T, Goto H, Izumiyama K, Otsuguro S, Perera LP, Hasegawa H, Maeda M, Hashino S, Maenaka K, Teshima T, Waldmann TA, Yang Y, Nakagawa M. Chiba M, et al. Among authors: otsuguro s. Blood. 2022 Nov 3;140(18):1951-1963. doi: 10.1182/blood.2022015646. Blood. 2022. PMID: 35921533 Free PMC article.

7

[Development of Integrated Database for Experiments and Simulations].

Yamada I, Kimura N, Nomura T, Otsuguro S, Miyachi H, Shigeta Y, Maenaka K. Yamada I, et al. Among authors: otsuguro s. Yakugaku Zasshi. 2024;144(5):539-543. doi: 10.1248/yakushi.23-00191-2. Yakugaku Zasshi. 2024. PMID: 38692930 Free article. Japanese.

8

Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus.

Anindita PD, Sasaki M, Okada K, Ito N, Sugiyama M, Saito-Tarashima N, Minakawa N, Shuto S, Otsuguro S, Ichikawa S, Matsuda A, Maenaka K, Orba Y, Sawa H. Anindita PD, et al. Among authors: otsuguro s. Antiviral Res. 2018 Jun;154:1-9. doi: 10.1016/j.antiviral.2018.03.011. Epub 2018 Mar 28. Antiviral Res. 2018. PMID: 29601893 Free article.

9

Structure, solubility, and permeability relationships in a diverse middle molecule library.

Miyachi H, Kanamitsu K, Ishii M, Watanabe E, Katsuyama A, Otsuguro S, Yakushiji F, Watanabe M, Matsui K, Sato Y, Shuto S, Tadokoro T, Kita S, Matsumaru T, Matsuda A, Hirose T, Iwatsuki M, Shigeta Y, Nagano T, Kojima H, Ichikawa S, Sunazuka T, Maenaka K. Miyachi H, et al. Among authors: otsuguro s. Bioorg Med Chem Lett. 2021 Apr 1;37:127847. doi: 10.1016/j.bmcl.2021.127847. Epub 2021 Feb 9. Bioorg Med Chem Lett. 2021. PMID: 33571648

10

Application of Acoustic Ejection MS System to High-Throughput Screening for SARS-CoV-2 3CL Protease Inhibitors.

Hasegawa T, Imamura RM, Suzuki T, Hashiguchi T, Nomura T, Otsuguro S, Maenaka K, Sasaki M, Orba Y, Sawa H, Sato A, Okabe T, Nagano T, Kojima H. Hasegawa T, et al. Among authors: otsuguro s. Chem Pharm Bull (Tokyo). 2022 Mar 1;70(3):199-201. doi: 10.1248/cpb.c21-01003. Epub 2021 Dec 21. Chem Pharm Bull (Tokyo). 2022. PMID: 34937844 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year